The US-China Pharma 2013 is a conference that covers topics such as:
- Strategies on how to mine the profits from Pharma Opportunities in China
- Identifing where are the profit potentials from Pharma Opportunities in China
- Adapt to China`s new healthcare system and protect and profit from intellectual property to profitably pricing and marketing brand, generic and biosimilar products
- Methods to sustain profitable growth over the long-term
The US-China Pharma 2013 brings together Senior Management from Biotech, Pharmaceuticals, Venture Capital, CROs and Academia in the US or China and involved in:
- Commercialization
- Market Research/ Analyst
- Market Access
- Licensing and Technology Transfer
- Corporate/Business Development
- Pricing and Reimbursement
- External R&D
- Strategic Alliance
- Clinical Development
- Outsourcing
- Regulatory Affairs
- Operations
- Government, Payer & Stakeholder Relation
- Translational Research
- Health Economics/Outcomes
